Madrigal Pharmaceuticals

MDGL

NASDAQHealth Care

Income Statement

Total Revenue$180.13M

Gross Profit$173.9M

Operating Income$-497.87M

EBITDA$-450.52M

EBIT$-451.22M

Pre-tax Income$-309.44M

Net Income$-465.89M

Cash Equivalent$366.2M

Total Debt$118.62M

Book Value$809.85M

Book Value Per Share38.23

Return on Equity (ROE)-61.76%

Return on Assets (ROA)-44.70%

Return on Invested Capital (ROI)-53.43%

Net Profit Margin-258.64%

Current Ratio6.10

Quick Ratio5.82

Long-Term Debt / Equity0.16